Psychedelic Institute of Mental Health & Family Therapy
Psychedelic Institute of Mental Health & Family Therapy
Telehealth Ketamine Therapists
⌘K
Contact
Psychedelic Institute of Mental Health & Family Therapy
Professional Development + Monthly Consultation and Clinical Practicum tiers-only post ketamine training

Ketamine Assisted Psychotherapy & Support Curriculum / Practicum

Developed by Michael DeMarco, LMFT, PhD, Psychedelic Institute of Mental Health & Family Therapy, Psyche, LLC, Founding Fellow | A 12 module, 96 hour cognitive-behavioral psychedelic apprenticeship including live demonstrations and experiential practice with physician-prescribed racemic ketamine
Michael DeMarco, PhD

by Michael DeMarco, PhD

Ketamine Assisted Psychotherapy & Support Curriculum / Practicum
Apply
Matrix - Decentralised and secure communication
You’re invited to talk on Matrix. If you don’t already have a client this link will help you pick one, and join the conversation. If you already have one, this link will help you join the conversation

Contact us for more information through Matrix (on Element)

Psychedelic Institute of Mental Health
ThePsychedelic Institute of Mental Health & Family Therapyis a psychedelic community of practice, research and support, offering professional development and supervision for psychedelic practitioners as well as general psychedelic mental health case management and counseling.
Eventbrite
This post is for subscribers on the Professional Development + Monthly Consultation and Clinical Practicum tiers only

Subscribe to continue reading


More like this

Ahora en Uruguay - una organización dedicada a la investigación, la educación y la promoción del uso de terapias asistidas con psicodélicos

Ahora en Uruguay - una organización dedicada a la investigación, la educación y la promoción del uso de terapias asistidas con psicodélicos

Nos encontramos desarrollando una iniciativa formativa orientada a profesionales en Uruguay, enfocada en el uso médico de la ketamina subanestésica para el tratamiento de condiciones como la depresión resistente, el trastorno por estrés postraumático y la ideación suicida

Spotlight: Psychedelics and mental health: reimagining care through science, insight, and compassion (Mikellides, et al, 2025)

"These substances are not stand-alone medications; rather, they function as adjuncts to intensive psychotherapeutic processes. Training therapists and establishing ethical, evidence-based protocols is essential."
Spotlight "Prefrontal contribution to passive coping behaviour in chronic stress and treatment by fast-acting antidepressant" (Fong, et al, 2025)

Spotlight "Prefrontal contribution to passive coping behaviour in chronic stress and treatment by fast-acting antidepressant" (Fong, et al, 2025)

"Persistent passive coping (p-coping) behaviour is a hallmark feature in major depression and is reversed by fast-acting antidepressants (such as ketamine)."

Spotlight: Ketamine as an Adjunct Therapy for Refractory Cancer Pain: A Case Report (Emshoff, et al, 2025)

"While traditionally recognized for its anesthetic and dissociative effects, low-dose, subanesthetic ketamine can be useful in palliative care to manage severe, intractable pain."

Enfoque Uruguay: Propuesta -- Estrategia Nacional de Drogas 2026-2030. Junta Nacional de Drogas

Programa Piloto de Psicoterapia Asistida con Psicodélicos en el Sistema de Salud Uruguayo | Michael DeMarco, PhD

Propuesta para la Estrategia Nacional de Drogas 2026–2030

Programa Piloto de Psicoterapia Asistida con Psicodélicos en el Sistema de Salud Uruguayo
Mastodon Mastodon